Jiangsu Skyray Instrument Valuation

Q: What is the Fair Price of 300165 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

300165 (CN¥3.82) is trading below our estimate of [[fair value]] (CN¥13.54)

Is 300165 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300165 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300165 (CN¥3.82) is trading below our estimate of fair value (CN¥13.54)

Significantly Below Fair Value: 300165 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300165?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 300165. This is calculated by dividing 300165's market cap by their current preferred multiple.
What is 300165's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CN¥1.89b

300165 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.3x
Enterprise Value/EBITDA	-102x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 300165's PS Ratio compare to its peers?

The above table shows the PS ratio for 300165 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	4.8x
688613 Allgens Medical Technology	11.6x	n/a	CN¥2.2b
300753 Jiangsu Apon Medical Technology	4.3x	n/a	CN¥1.7b
300412 Zhejiang Canaan Technology	1.8x	n/a	CN¥2.0b
300246 Guangdong Biolight Meditech	1.7x	n/a	CN¥1.8b
300165 Jiangsu Skyray Instrument	2x	n/a	CN¥1.9b

Price-To-Sales vs Peers: 300165 is good value based on its Price-To-Sales Ratio (2x) compared to the peer average (4.8x).

Price to Earnings Ratio vs Industry

How does 300165's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	27.5%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	27.5%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: 300165 is good value based on its Price-To-Sales Ratio (2x) compared to the CN Medical Equipment industry average (6x).

Price to Sales Ratio vs Fair Ratio

What is 300165's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300165 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 300165's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.